A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)
Public ClinicalTrials.gov record NCT01302587. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Open Label, Assessment of [an Albuterol] Hydrofluoroalkane (HFA) Metered Dose Inhaler MDI Integrated Dose Counter
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is evaluating the effectiveness of a dose counter for an inhaler device used to deliver medication to people diagnosed with asthma or COPD.
Study identification
- NCT ID
- NCT01302587
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 306 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 4 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2011
- Primary completion
- May 31, 2011
- Completion
- May 31, 2011
- Last update posted
- Jun 21, 2012
2011
United States locations
- U.S. sites
- 25
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Clinical Study Site | Glendale | Arizona | — | — |
| Teva Clinical Study Site 10100 | Mission Viejo | California | — | — |
| Teva Clinical Study Site 10093 | Orange | California | — | — |
| Teva Clinical Study Site 10089 | San Diego | California | — | — |
| Teva Clinical Study Site 10098 | Wheat Ridge | Colorado | — | — |
| Teva Clinical Study Site | Miami | Florida | — | — |
| Teva Clinical Study Site 10082 | Ormond Beach | Florida | — | — |
| Teva Clinical Study Site | Tamarac | Florida | — | — |
| Teva Clinical Study Site 10090 | Indianapolis | Indiana | — | — |
| Teva Clinical Study Site 10097 | Overland Park | Kansas | — | — |
| Teva Clinical Study Site 10087 | Wichita | Kansas | — | — |
| Teva Clinical Study Site | Fall River | Massachusetts | — | — |
| Teva Clinical Study Site 10094 | North Dartmouth | Massachusetts | — | — |
| Teva Clinical Study Site 10086 | Minneapolis | Minnesota | — | — |
| Teva Clinical Study Site 10083 | High Point | North Carolina | — | — |
| Teva Clinical Study Site 10092 | Raleigh | North Carolina | — | — |
| Teva Clinical Study Site 10085 | Canton | Ohio | — | — |
| Teva Clinical Study Site 10080 | Tulsa | Oklahoma | — | — |
| Teva Clinical Study Site 10088 | Eugene | Oregon | — | — |
| Teva Clinical Study Site 10095 | Portland | Oregon | — | — |
| Teva Clinical Study Site 10081 | Greenville | South Carolina | — | — |
| Teva Clinical Study Site 10084 | Spartanburg | South Carolina | — | — |
| Teva Clinical Study Site | Dallas | Texas | — | — |
| Teva Clinical Study Site 10091 | New Braunfels | Texas | — | — |
| Teva Clinical Study Site 10099 | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01302587, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2012 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01302587 live on ClinicalTrials.gov.